This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
HW: In 2021 you partnered with growth firm TPG to bring them on as your primary investor, which I assume gave your current venture capital partners a chance to at least partially exit the business. We ended up partnering with two different funds at TPG; the TPG Growth Fund and the RISE Fund. I will finish here.
In addition, there will be 8 thematic panels: LeveragedBuyout, Real Estate, Energy, Distressed, Venture Capital & Growth, Media & Entertainment, Emerging Markets, and Limited Partners & Secondaries.
Ten years ago, I was an analyst for the General Motors pension fund, working on fund investments into leveragedbuyout funds and venture capital deals. In fact, the one area I was pretty set on eliminating from my consideration set--leveragedbuyouts--was the area where partners seemed to make the most money.
While he’s gotten lots of criticism for specific failures like the enormous take private (via a leveragedbuyout) – and subsequent bankruptcy a year later – of the Tribune Company, he doesn’t dodge his mistakes in this book. It had an emotional tenor that is similar to my feelings for my partners.
I'm general partner at MarsBio VC and Director of The Corona Initiative. I saw him just work so hard on this diagnostics company where he partnered with this scientist that had developed a called it a risk assessment or a diagnostic to basically determine one's risk of stroke and heart attack. Robert Rhinehart : Hi.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content